Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS.Work Package 5A and 5B: A pilot cluster randomised study of the management toolkit in the NHS secondary care services

orthumberland, Tyne and Wear NHS Foundation Trust0 个研究点目标入组 131 人开始时间: 2017年1月20日最近更新: 2024年2月27日

适应症

试验速览

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/32960456/ results (added 23/09/2020) 2021 Other publications in https://doi.org/10.1212/WNL.0000000000012450 Secondary analysis (added 13/02/2024) 2021 Results article in https://doi.org/10.3310/pgfar09070 (added 13/02/2024)

•1. A clinician diagnosis of LBD has been documented as the result of specialist service assessment (possible or probable diagnosis)
•2. Consent can be obtained from the patient or, for those subjects lacking capacity, from a consultee
•In addition to the above criteria:
•WP5A: Patients aged 60 and over with at least 1 active clinical issue as determined by the treating clinical team.
•WP5B: Patients aged 60 and over with a diagnosis of Parkinson’s disease where a memory problem has developed.

•1. Patients who have explicitly expressed a wish not to be approached to take part in research
•2. Patients who have been approached to take part in this study previously (as part of another participating service)
•3. Patients who have a severe or terminal illness and reduced life expectancy which compromises their ability to comply with the protocol
•4. Insufficient English to allow completion of the study measures
•5. Patients who are assessed as not able to complete the outcome measures for the study. Clinicians may choose not to use the management tool at some assessments if they feel it is not appropriate.

发起方

orthumberland, Tyne and Wear NHS Foundation Trust